Corrigendum to “Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19” [Pharmacol. Res. 164 (2021) 105402]

Publication date: Available online 7 April 2021Source: Pharmacological ResearchAuthor(s): Emilio Di Maria, Paolo Martini, Massimo Gennarelli

Source: Pharmacological Research - April 9, 2021 Category: Drugs & Pharmacology Source Type: research